Emily Schoenthaler is a content producer for BioPharm International.
As part of our continuing coverage from the BIO International Convention 2026, Pharmaceutical Executive spoke with Martha Fowler, founder of Steer Bio, about the company's regenerative medicine platform, its lead program for cancer-related lymphedema, and how non-dilutive funding is supporting its path toward first-in-human studies.
At the BIO International Convention 2026 in San Diego, CA, last month, Pharmaceutical Executive caught up with Christy Wyskiel, executive director of Johns Hopkins Technology Ventures, to discuss how the institution is translating research into commercial products, supporting startup creation, and strengthening Baltimore's life sciences innovation community through strategic partnerships.
Abu Dhabi is expanding its role in global biopharmaceutical manufacturing through strategic investments, advanced infrastructure, and international partnerships designed to accelerate biologics production, innovation, and supply chain resilience.
